Some researchers found that the abnormal expression of C-MYC could lead to obvious changes in ferritin and Fe2+ content in ovarian cancer cells, while they also found that these changes were significantly correlated with NCOA4 expression [9,10,11,12,13]. This evidence concerns the gene NCOA4 and ovarian carcinoma.